Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid and accurate analysis of complex genomic data.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
